FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | "potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic" | 15 mmol; 15 mmol | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Diltiazem Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Diltiazem Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Esmolol Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Acetaminophen | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Acetaminophen | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Acetaminophen | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .02 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .75 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .75 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-14 |